$1.1B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | LQDA Liquidia Corporation | 2.4M | −3.8% | $195M | 17.7% |
| 2 | ETON Eton Pharmaceuticals Inc | 2.9M | +0.0% | $104M | 9.4% |
| 3 | HROW Harrow Inc | 2.4M | −15.3% | $102M | 9.2% |
| 4 | IRON Disc Medicine Inc | 855,000 | +103.1% | $63M | 5.7% |
| 5 | URGN Urogen Pharma Ltd | 1.4M | +0.7% | $53M | 4.8% |
| 6 | APOGEE THERAPEUTICS INC Apogee Therapeutics Inc | 390,000 | +0.0% | $52M | 4.7% |
| 7 | MGTX Meiragtx Hldgs Plc | 3.5M | +67.2% | $48M | 4.3% |
| 8 | SLGL Sol-Gel Technologies Ltd | 500,000 | +0.0% | $37M | 3.4% |
| 9 | RZLT Rezolute Inc | 6.3M | +0.0% | $33M | 3.0% |
| 10 | TGTX Tg Therapeutics Inc | 535,000 | +0.0% | $29M | 2.7% |
| 11 | IMMX Immix Biopharma Inc | 2.3M | — | $24M | 2.2% |
| 12 | CBIO Crescent Biopharma Inc. | 1.3M | +0.5% | $24M | 2.2% |
| 13 | STOK Stoke Therapeutics Inc | 700,000 | +0.0% | $23M | 2.1% |
| 14 | ACOG Alpha Cognition Inc | 2.9M | +13.0% | $21M | 1.9% |
| 15 | EWTX Edgewise Therapeutics Inc | 500,000 | +0.0% | $20M | 1.8% |
| 16 | RVMD Revolution Medicines Inc | 100,000 | +0.0% | $19M | 1.7% |
| 17 | GLUE Monte Rosa Therapeutics Inc | 745,000 | — | $18M | 1.6% |
| 18 | ALMS Alumis Inc | 550,000 | +0.0% | $15M | 1.4% |
| 19 | CDXS Codexis Inc | 6.8M | +0.0% | $15M | 1.4% |
| 20 | REPL Replimune Group Inc | 1.4M | — | $15M | 1.4% |
| 21 | XOMA ROYALTY CORPORATION Xoma Royalty Corporation | 338,374 | +12.8% | $14M | 1.3% |
| 22 | MBX Mbx Biosciences Inc | 260,000 | +0.0% | $14M | 1.3% |
| 23 | RYTM Rhythm Pharmaceuticals Inc | 122,500 | −0.4% | $14M | 1.2% |
| 24 | EDIT Editas Medicine Inc | 3.9M | +100.4% | $13M | 1.1% |
| 25 | PTGX Protagonist Therapeutics Inc | 100,000 | +0.0% | $12M | 1.1% |
| 26 | CABA Cabaletta Bio Inc | 3.9M | +180.0% | $12M | 1.1% |
| 27 | QTTB Q32 Bio Inc | 931,000 | −25.9% | $12M | 1.1% |
| 28 | ANNX Annexon Inc | 1.7M | −26.5% | $10M | 0.9% |
| 29 | VSTM Verastem Inc | 1.8M | — | $7M | 0.6% |
| 30 | ZNTL Zentalis Pharmaceuticals Inc | 1.4M | +0.0% | $7M | 0.6% |
| 31 | RLMD Relmada Therapeutics Inc | 935,000 | +0.0% | $6M | 0.6% |
| 32 | OCUL Ocular Therapeutix Inc | 600,000 | +0.0% | $6M | 0.5% |
| 33 | TRVI Trevi Therapeutics Inc | 310,000 | −10.2% | $6M | 0.5% |
| 34 | BBOT Bridgebio Oncology Therapeut | 700,000 | +1213.8% | $5M | 0.5% |
| 35 | LYEL Lyell Immunopharma Inc | 344,025 | +334.9% | $5M | 0.4% |
| 36 | IRD Opus Genetics Inc | 1.1M | +0.4% | $5M | 0.4% |
| 37 | FDMT 4D Molecular Therapeutics In | 334,437 | +197.8% | $4M | 0.4% |
| 38 | NTLA Intellia Therapeutics Inc | 250,000 | +2.0% | $4M | 0.4% |
| 39 | VYGR Voyager Therapeutics Inc | 1.2M | +3.0% | $4M | 0.4% |
| 40 | BDSX Biodesix Inc | 180,000 | −24.4% | $4M | 0.4% |
| 41 | RCKT Rocket Pharmaceuticals Inc | 1.0M | +4.7% | $3M | 0.3% |
| 42 | JBIO Jade Biosciences Inc | 145,000 | −66.1% | $3M | 0.3% |
| 43 | SNWV Sanuwave Health Inc | 306,140 | −68.8% | $3M | 0.3% |
| 44 | FBIO Fortress Biotech Inc | 890,000 | −14.6% | $3M | 0.2% |
| 45 | DERM Journey Med Corp | 350,000 | −63.5% | $2M | 0.2% |
| 46 | PHAT Phathom Pharmaceuticals Inc | 185,589 | — | $2M | 0.2% |
| 47 | INBX Inhibrx Biosciences Inc | 20,291 | — | $2M | 0.2% |
| 48 | ENTA Enanta Pharmaceuticals Inc | 125,000 | +0.0% | $2M | 0.2% |
| 49 | COAG Hemab Therapeutics Hldgs Inc | 47,652 | — | $2M | 0.2% |
| 50 | TRAX First Tracks Biotherapeutics | 65,000 | — | $1M | 0.1% |